U.S. District Court Issues Decision on REGENXBIO and University of Pennsylvania NAV® Technology Patent Infringement Lawsuit
ROCKVILLE, Md., Jan. 8, 2024 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced the U.S. District Court for the District of Delaware granted Sarepta Therapeutics, Inc. (Sarepta) summary judgment on invalidity in a patent infringement suit arising from Sarepta’s manufacture and
Evergreen Home Loans Promotes Siara Jay to the Position of Branch Manager for the Enumclaw Branch, Following the Retirement of Tara Rose
BELLEVUE, Wash., Jan. 8, 2024 /PRNewswire/ — Evergreen Home Loans, a full-service direct home loan lender offering origination, funding, and servicing throughout the Western U.S., is pleased to announce the retirement of Tara Rose, the dedicated Evergreen Branch Manager with over 30 years of e
Haystack Oncology and Alliance Foundation Trials collaborate to use Haystack MRD™ technology in phase II clinical trial for unresectable stage III NSCLC
BALTIMORE, Jan. 8, 2024 /PRNewswire/ — Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, has entered into a collaboration with Alliance Foundation Trials, LLC (AFT) for research use of Haystack Oncology’s personalized MRD technology (Haystack MRD™) to analyze therapeutic resp
MediDrive®, a CTG Partner Company, announces formal entry into the Non-Emergency Medical Transportation Market
The new company’s mission is to address the critical issue of transportation as a social determinant capable of driving materially improved health outcomes by providing compassionate access to care. BROOKLYN, N.Y., Jan. 8, 2024 /PRNewswire/ — For over forty-five years, the Corporate Tran
WPG Americas Inc. Rick Hylka Receives Top Distribution FAE Award from Micron Technology Inc.
SAN JOSE, Calif., Jan. 8, 2024 /PRNewswire/ — WPG Americas, Inc. (WPGA), a subsidiary of WPG Holdings, a global leading, and largest electronics distributor in Asia*, and now one of the fastest growing in the United States, announced today that Rick Hylka, Innovation Tech Center (ITC) Applicat
CollPlant’s CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
REHOVOT, Israel, Jan. 8, 2024 /PRNewswire/ — CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced that
/R E M I N D E R — Media Advisory – Deputy Prime Minister’s itinerary for Monday, January 8, 2024/
OTTAWA, ON, Jan. 7, 2024 /CNW/ – Note: All times local. Greater Toronto Area, Ontario Private meetings. 3:30 p.m. The Deputy Prime Minister will join the Prime Minister at an event to commemorate the Ukraine International Airlines Flight 752 tragedy. The Minister of Foreign Affairs, Mélanie
Arctech Enables Grid Connection of 400MW for CEEC’s Solar Flagship in Uzbekistan’s Renewables Breakthrough
TASHKENT, Uzbekistan, Jan. 8, 2024 /PRNewswire/ — Arctech, the premier solar tracking system provider with over 3GW of contracts in Uzbekistan, announced that its SkyWings single-axis trackers have enabled the on-schedule grid connection of the first 400MW phase of China Energy Engineering Gro
KBR Green Ammonia Technology Selected by Lotte Chemical Corporation for H2biscus Project in Malaysia
HOUSTON, Jan. 8, 2024 /PRNewswire/ — KBR (NYSE: KBR) announced today that its K-GreeN® technology has been selected by a consortium consisting of Lotte Chemical, KNOC (Korea National Oil Corp) and Samsung Engineering for Lotte Chemical’s H2biscus green ammonia project development in Sar
Nutraceutical Excipients Market worth $6.1 billion by 2028 – Exclusive Report by MarketsandMarkets™
CHICAGO, Jan. 8, 2024 /PRNewswire/ — The Nutraceutical Excipients Market will grow from USD 4.2 billion in 2023 to USD 6.1 billion by 2028, growing at a CAGR of 7.7% from 2023 to 2028 according to a report published by MarketsandMarkets™. The burgeoning popularity of nutraceuticals in rece
